Resistance of gliomas to temozolomide may manifest due to alterations in the HOTAIR-miR125 signaling axis, via hyperactivation of hexokinase 2 (HK2)-mediated glycolytic pathway in tumor cells (Zhang et al. 2020a). The gene discussed is HK2; the disease is central nervous system cancer.